Steven Cohen Century Therapeutics, Inc. Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.4 - $5.11 $279,140 - $419,531	-82,100 Closed	0 $0
Q4 2022 Feb 14, 2023	SELL	$4.84 - $11.58 $402,204 - $962,298	-83,100 Reduced 50.3%	82,100 $421,000
Q3 2022 Nov 14, 2022	SELL	$8.57 - $13.1 $2.71 Million - $4.14 Million	-315,800 Reduced 65.65%	165,200 $1.63 Million
Q2 2022 Aug 15, 2022	BUY	$7.96 - $12.43 $108,335 - $169,172	13,610 Added 2.91%	481,000 $4.04 Million
Q1 2022 May 16, 2022	BUY	$11.62 - $15.92 $657,575 - $900,912	56,590 Added 13.78%	467,390 $5.88 Million

Q4 2021 Feb 14, 2022	BUY	$13.93 - $23.62 $5.72 Million - $9.7 Million	410,800 New	410,800 $6.52 Million

19.7M

10.6K

300

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $150M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.